Literature DB >> 9686438

Potential tumour doubling time: determination of Tpot for various canine and feline tumours.

U Schwyn1, N E Crompton, H Blattmann, B Hauser, B Klink, A Parvis, D Ruslander, B Kaser-Hotz.   

Abstract

Spontaneous tumours in dogs and cats are an excellent model for clinical human research, such as in developing proton conformation radiotherapy for humans. The kinetics of tumour cells can be used effectively to predict prognosis and response to therapy in patients with tumours. Knowledge of the kinetic parameters in these tumours is therefore important. In the present study the kinetic parameters evaluated included the labelling index (LI), relative movement (RM), mitotic index (MI), and potential doubling time (Tpot). These parameters were determined using in vivo labelling with bromodeoxyuridine, flow cytometry and histological preparation. Samples were obtained and evaluated from 72 dogs and 20 cats, presenting as patients in our clinic. Within the groups of epithelial and mesenchymal tumours from dogs and cats, the kinetic parameters LI, RM and MI were compared with Tpot. Significant correlations were observed for the comparison Tpot and LI. No correlation was found between Tpot and RM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9686438     DOI: 10.1023/a:1006087114421

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  29 in total

1.  DEOXYRIBONUCLEIC ACID METABOLISM IN VIVO: I. CELL PROLIFERATION AND DEATH AS MEASURED BY INCORPORATION AND ELIMINATION OF IODODEOXYURIDINE.

Authors:  W L HUGHES; S L COMMERFORD; D GITLIN; R C KRUEGER; B SCHULTZE; V SHAH; P REILLY
Journal:  Fed Proc       Date:  1964 May-Jun

2.  Evaluation of flow cytometric methods for determining population potential doubling times using cultured cells.

Authors:  N H Terry; R A White; M L Meistrich; D P Calkins
Journal:  Cytometry       Date:  1991

3.  A rapid flow cytometric method for bivariate bromodeoxyuridine/DNA analysis using simultaneous proteolytic enzyme digestion and acid denaturation.

Authors:  P E van Erp; P P Brons; J B Boezeman; G J de Jongh; F W Bauer
Journal:  Cytometry       Date:  1988-11

4.  Comparison of fresh, ethanol-preserved, and paraffin-embedded samples in DNA flow cytometry.

Authors:  K A Alanen; P J Klemi; H Joensuu; H Kujari; E Pekkala
Journal:  Cytometry       Date:  1989-01

5.  A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.

Authors:  T J Kinsella; A Russo; J B Mitchell; J Rowland; J Jenkins; J Schwade; C E Myers; J M Collins; J Speyer; P Kornblith
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-01       Impact factor: 7.038

6.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

7.  Potential for increasing the differential response between tumors and normal tissues: can proliferation rate be used?

Authors:  J F Fowler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-04       Impact factor: 7.038

8.  Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.

Authors:  G D Wilson; N J McNally; S Dische; M I Saunders; C Des Rochers; A A Lewis; M H Bennett
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

9.  Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation.

Authors:  Y Remvikos; P Vielh; E Padoy; B Benyahia; N Voillemot; H Magdelénat
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

10.  Proliferative activity of human tumors: assessment using bromodeoxyuridine and flow cytometry.

Authors:  T Shimomatsuya; N Tanigawa; R Muraoka
Journal:  Jpn J Cancer Res       Date:  1991-03
View more
  1 in total

1.  Retrospective clinical study on outcome in cats with nasal planum squamous cell carcinoma treated with an accelerated radiation protocol.

Authors:  Evgeniya Gasymova; Valeria Meier; Franco Guscetti; Simona Cancedda; Malgorzata Roos; Carla Rohrer Bley
Journal:  BMC Vet Res       Date:  2017-04-04       Impact factor: 2.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.